Survival Benefit With Checkpoint Inhibitors Versus Chemotherapy is Modified by Brain Metastases in Patients With Recurrent Small-Cell Lung Cancer

While CPI was associated with a lower risk of 1-year mortality compared to chemotherapy. the effect on overall survival was significantly modified by intracranial disease and radiotherapy, suggesting the benefit was driven by patients without brain metastases.

Access the full article to read more here.